BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Noxilizer's David Opie to Present at Prefilled Syringe Forum, Md&M East & World of Prefilled Syringes & Injectable Devices This Summer


6/4/2013 8:43:08 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

(Baltimore, MD—June 3, 2013) -- David Opie, Ph.D., Senior Vice President, Research & Development, will address prefilled syringe and medical device audiences at industry conferences in June and July. A new advance in sterilization, nitrogen dioxide (NO2) offers many benefits over traditional methods. NO2 sterilization is room temperature, leaves no cytotoxic residuals, operates without a vacuum, provides surface sterilization and maintains material and drug integrity. Through a case study, David will illustrate the mechanism of kill, cycle description, residuals, biocompatibility data, safety and financial benefits of NO2 as an alternative for manufacturers.

PharmaEd Prefilled Syringe Forum 2013, June 6th in Philadelphia

David will be presenting “New Sterilization Solutions for Prefilled Syringes” at 4:30 pm.

MD&M East 2013, June 18th in Philadelphia

David will present “Low Temperature Sterilization: Discussion of Current Methods including Nitrogen Dioxide” in the Innovations Brief Theater on the show room floor, booth #957 at 1:30 pm. Noxilizer will also be exhibiting at booth #3159.

World of Prefilled Syringes & Injectable Devices Americas 2013, July 11th in Boston

David will detail “New Sterilization Solutions for Prefilled Syringes/Injectable Devices” at 2:00 pm.

About Noxilizer, Inc.:

Noxilizer has a unique and superior room temperature NO2-based sterilization technology that is revolutionizing two major sterilization markets — medical device/pharmaceutical/biotechnology manufacturing and hospitals. In the manufacturing market, Noxilizer provides sterilization services for medical devices and drug/device combination products. Noxilizer sells the RTS 360 Industrial NO2 Sterilizer to companies who sterilize products in-house and also offers contract sterilization services. In hospitals, Noxilizer is developing a system especially for sensitive, high-tech equipment used in minimally-invasive surgical procedures. Noxilizer is headquartered in Baltimore, MD with offices in the US and Japan. Noxilizer, Inc. is privately held and was founded in 2004. For more information about Noxilizer, please visit: www.noxilizer.com.

Media Contact:

Angie Kearns

Brand Manager

Noxilizer, Inc.

C (574) 304-1502

akearns@noxilizer.com



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

Noxilizer
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES